Overview GAIA’s digital therapeutic deprexis is now reimbursable in Switzerland for patients with mild to moderate depression and recurrent depressive disorders under the country’s man...
Conversations Shaping Tomorrow's Healthcare
Overview GAIA’s digital therapeutic deprexis is now reimbursable in Switzerland for patients with mild to moderate depression and recurrent depressive disorders under the country’s man...